Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating highly active natural killer cell immunotherapy for small metastases in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED